Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.78
+1.06 (1.18%)
At close: Jun 26, 2026, 4:00 PM EDT
91.35
+0.57 (0.63%)
After-hours: Jun 26, 2026, 7:11 PM EDT

Edwards Lifesciences Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $96.92. The average 1-year stock price forecast is 6.76% higher than the current stock price, while the lowest is $84 (-7.47%) and the highest is $110 (+21.17%).

Price Target: $96.92 (+6.76%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$84$96.92$100$110
Change-7.47%+6.76%+10.16%+21.17%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy161616171717
Buy555544
Hold121210888
Sell000000
Strong Sell000000
Total333331302929

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Hold
Reiterates
$87
HoldReiterates$87-4.16%Jun 16, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 16, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$98
BuyMaintains$98+7.95%Jun 16, 2026
Truist Financial
Truist Financial
Hold
Maintains
n/a
HoldMaintainsn/an/aJun 16, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 16, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.75B
from 6.07B
Increased by 11.21%
Revenue Next Year
7.41B
from 6.75B
Increased by 9.82%
EPS This Year
3.01
from 2.56
Increased by 17.48%
EPS Next Year
3.37
from 3.01
Increased by 11.98%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.23B4.46B5.01B5.44B6.07B6.75B
Revenue Growth
19.29%-14.69%12.23%8.57%11.55%11.21%
Gross Profit
3.98B3.74B4.03B4.32B4.73B5.29B
Gross Margin
76.13%83.82%80.47%79.46%78.01%78.41%
Operating Income
1.59B1.54B1.49B1.48B1.64B1.96B
Net Income
1.50B1.52B1.40B4.17B1.07B1.62B
EPS
----2.563.01
EPS Growth
----5.35%17.48%
Forward PE
52.9830.3528.4131.1930.9330.19
Free Cash Flow
1.01B776.73M566.93M1.34B1.17B1.36B
No. Analysts
-----28
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.8B
Avg6.7B
Low6.6B

Revenue Growth

Revenue Growth202620272028
High
12.3%
Avg
11.2%
Low
9.1%

EPS Forecast

EPS202620272028
High3.05
Avg3.01
Low2.97

EPS Growth

EPS Growth202620272028
High
19.1%
Avg
17.5%
Low
16.0%